Cargando…
Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia
Benign prostate disease is a disease of prevalence and over 25% of men affected by bothersome lower urinary tract symptoms (LUTS) as a result of it will require surgical intervention during their lifetime. While transurethral resection of the prostate (TURP) has served as the cornerstone treatment f...
Autores principales: | Jones, Patrick, Siena, Giampaolo, Hameed, B M Zeeshan, Somani, Bhaskar K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290348/ https://www.ncbi.nlm.nih.gov/pubmed/34295845 http://dx.doi.org/10.2147/RRU.S273686 |
Ejemplares similares
-
Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022) -
Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
por: Huang, Yiyu, et al.
Publicado: (2020) -
Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature
por: Cocci, Andrea, et al.
Publicado: (2021) -
Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007) -
Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
por: El-Tabey, Magdy, et al.
Publicado: (2015)